Novartis | Revenu Net



Net Income Changement Date
AbbVie USD 938M 348M 2025-06
Amgen USD 1.73B 1.1B 2025-03
AstraZeneca USD 2.45B 466M 2025-06
Bausch Health Companies USD 148M 206M 2025-06
Biogen USD 634.8M 394.3M 2025-06
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Canopy Growth CAD -121896000 6.4M 2024-12
Corcept Therapeutics USD 35.15M 14.6M 2025-06
Drreddys Laboratories INR 14.13B 1.58B 2024-12
Eli Lilly USD 5.66B 2.9B 2025-06
Gilead Sciences USD 1.96B 645M 2025-06
GlaxoSmithKline GBP 1.44B 181M 2025-06
Glaxosmithkline GBP 414M 472M 2024-12
J&J USD 5.54B 5.46B 2025-06
Merck USD 4.43B 652M 2025-06
Novartis USD 4.02B 418M 2025-06
Novartis USD 2.82B 371M 2024-12
Pacira USD -4847000 9.66M 2025-06
Perrigo USD -8400000 2M 2025-06
Pfizer USD 2.91B 58M 2025-06
Prestige Brands USD 61.78M 11.65M 2025-06
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 3.94B 2.07B 2025-06
Sanofi EUR 499M 2.32B 2024-12
Supernus Pharmaceuticals USD 22.5M 34.33M 2025-06
Zoetis USD 718M 87M 2025-06


Novartis Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.